Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations.

Abstract

BACKGROUND AND PURPOSE We sought to investigate the feasibility of the combined use of low-dose recombinant tissue plasminogen activator (rtPA) and tirofiban, a glycoprotein IIb/IIIa (GPIIb/IIIa) receptor antagonist, for systemic thrombolysis in acute stroke. METHODS Consecutive patients who were treated with systemic application of low-dose rtPA and body… (More)

Topics

Cite this paper

@article{Seitz2003ThrombolysisWR, title={Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations.}, author={R{\"{u}diger J. Seitz and Magnolia Hamzavi and Ulrich Junghans and Peter Ringleb and Corinna Schranz and Mario Siebler}, journal={Stroke}, year={2003}, volume={34 8}, pages={1932-5} }